Outcome of special types of luminal breast cancer

Goldhirsch, 2009, Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer, Ann Oncol, 20, 1319, 10.1093/annonc/mdp322 Goldhirsch, 2011, Strategies for subtypes: dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011, Ann Oncol, 22, 1736, 10.1093/annonc/mdr304 Page, 2003, Special types of invasive breast cancer, with clinical implications, Am J Surg Pathol, 27, 832, 10.1097/00000478-200306000-00016 Ellis, 2003, Invasive breast carcinoma, 13 Rosen, 1993, Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up, J Clin Oncol., 11, 2090, 10.1200/JCO.1993.11.11.2090 Rakha, 2010, Tubular carcinoma of the breast: further evidence to support its excellent prognosis, J Clin Oncol, 28, 99, 10.1200/JCO.2009.23.5051 Page, 1983, Invasive cribriform carcinoma of the breast, Histopathology, 7, 525, 10.1111/j.1365-2559.1983.tb02265.x Clayton, 1986, Pure mucinous carcinomas of breast: morphologic features and prognostic correlates, Hum Pathol, 17, 34, 10.1016/S0046-8177(86)80152-6 Weigelt, 2009, Histological and molecular types of breast cancer: is there a unifying taxonomy?, Nat Rev Clin Oncol, 6, 718, 10.1038/nrclinonc.2009.166 Cheang, 2009, Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer, J Natl Cancer Inst, 101, 736, 10.1093/jnci/djp082 Veronesi, 2003, A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N Engl J Med, 349, 546, 10.1056/NEJMoa012782 Tavassoli, 2003, 13 Rosen, 1992 Colleoni, 1999, Prediction of response to primary chemotherapy for operable breast cancer, Eur J Cancer, 35, 574, 10.1016/S0959-8049(99)00005-2 Elston, 2002, Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer-Experience from a large study with long-term follow-up, Histopathology, 41, 151, 10.1046/j.1365-2559.2002.14691.x Rosen, 2009, Mucinous carcinoma, 515 Hugh, 2009, Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 Trial, J Clin Oncol, 27, 1168, 10.1200/JCO.2008.18.1024 Goldhirsch, 1998, Meeting highlights—International Consensus Panel on the treatment of primary breast cancer, J Natl Cancer Inst, 90, 1601, 10.1093/jnci/90.21.1601 Goldhirsch, 2001, Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer, J Clin Oncol, 19, 3817, 10.1200/JCO.2001.19.18.3817 Fisher, 1990, J Clin Oncol, 8, 1483, 10.1200/JCO.1990.8.9.1483 Colleoni, 2002, Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF, Br J Cancer, 86, 1705, 10.1038/sj.bjc.6600334 Ellis, 1992, Pathological prognostic factors in breast cancer: II. Histological type—relationship with survival in a large study with long-term follow-up, Histopathology, 20, 479, 10.1111/j.1365-2559.1992.tb01032.x Fitzgibbons, 2000, Prognostic factors in breast cancer: College of American Pathologists Consensus Statement 1999, Arch Pathol Lab Med, 124, 966, 10.5858/2000-124-0966-PFIBC Pereira, 1995, Pathological prognostic factors in breast cancer. IV: should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma, Histopathology, 27, 219, 10.1111/j.1365-2559.1995.tb00213.x Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 Rosen, 2001, Cribriform carcinoma, 551 Venable, 1990, Infiltrating cribriform carcinoma of the breast: a distinctive clinicopathologic entity, Hum Pathol, 21, 333, 10.1016/0046-8177(90)90235-W Louwman, 2007, Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands, Int J Cancer, 121, 127, 10.1002/ijc.22625 Abdel-Fatah, 2008, Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family, Am J Surg Pathol, 32, 513, 10.1097/PAS.0b013e318161d1a5 Weigelt, 2008, Refinement of breast cancer classification by molecular characterization of histological special types, J Pathol, 216, 141, 10.1002/path.2407 Diab, 1999, Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas, J Clin Oncol, 17, 1442, 10.1200/JCO.1999.17.5.1442 Deos, 1982, Well-differentiated (tubular) carcinoma of the breast: a clinicopathologic study of 145 pure and mixed cases, Am J Clin Pathol, 8, 1, 10.1093/ajcp/78.1.1 Green, 1997, A comparative study of pure tubular and tubulolobular carcinoma of the breast, Am J Surg Pathol, 21, 653, 10.1097/00000478-199706000-00004 Javid, 2009, Tubular carcinoma of the breast: results of a large contemporary series, Am J Surg, 197, 674, 10.1016/j.amjsurg.2008.05.005 Kitchen, 2001, Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapy, ANZ J Surg, 71, 27, 10.1046/j.1440-1622.2001.02022.x Winchester, 1996, Tubular carcinoma of the breast: predicting axillary nodal metastases and recurrence, Ann Surg, 223, 342, 10.1097/00000658-199603000-00015 Lopez-Garcia, 2010, Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomas, J Pathol, 222, 64 Komaki, 1988, Mucinous carcinoma of the breast in Japan: a prognostic analysis based on morphologic features, Cancer, 61, 989, 10.1002/1097-0142(19880301)61:5<989::AID-CNCR2820610522>3.0.CO;2-E Weigelt, 2009, Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type, Mod Pathol, 22, 1401, 10.1038/modpathol.2009.112 Di Saverio, 2008, A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma, Breast Cancer Res Treat, 111, 541, 10.1007/s10549-007-9809-z Toikkanen, 1989, Pure and mixed mucinous carcinoma of the breast: a clinicopathologic analysis of 61 cases with long-term follow up, Hum Pathol, 20, 758, 10.1016/0046-8177(89)90069-5 Andre´, 1995, Mucinous carcinoma of the breast: a pathologic study of 82 cases, J Surg Oncol, 58, 162, 10.1002/jso.2930580305 du Toit, 1991, An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast, Eur J Surg Oncol, 17, 251 Cristofanilli, 2005, Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes, J Clin Oncol, 23, 41, 10.1200/JCO.2005.03.111 Toikkanen, 1997, Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma, Br J Cancer, 76, 1234, 10.1038/bjc.1997.540 Pestalozzi, 2008, Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 international breast cancer study group clinical trials, J Clin Oncol, 26, 3006, 10.1200/JCO.2007.14.9336 Santiago, 2005, Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: the University of Pennsylvania experience, Cancer, 103, 2447, 10.1002/cncr.21071 Tubiana-Hulin, 2006, Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution, Ann Oncol, 17, 1228, 10.1093/annonc/mdl114 Mhuircheartaigh, 2008, Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma, Br J Surg, 95, 827, 10.1002/bjs.6042 Rakha, 2008, Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes, Eur J Cancer, 44, 73, 10.1016/j.ejca.2007.10.009 Bullet, 2008, High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies, Br J Cancer, 98, 734, 10.1038/sj.bjc.6604229 Sastre-Garau, 1996, Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns, Cancer, 77, 113, 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8 Rakha, 2009, The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology, Breast Cancer Res Treat, 114, 243, 10.1007/s10549-008-0007-4